Paper

Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

Published Apr 1, 2000 · Edward A. Lew, J. Pisegna, Julie A. Starr

Gastroenterology

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Highly Cited

Study Snapshot

Intravenous pantoprazole effectively controls gastric acid output within 1 hour and maintains control for up to 7 days in all Zollinger-Ellison syndrome patients without serious adverse events.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

References

Citations